Sponsor:
Kyverna Therapeutics
Code:
NCT07403188
Conditions
Refractory Lupus Nephritis
Myasthaenia Gravis
Stiff Person Syndrome
Rheumatoid Arthritis (RA)
Multiple Sclerosis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
KYV-101
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-30. This information was provided to ClinicalTrials.gov by Kyverna Therapeutics on 2026-02-11.